SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001557142-21-000058
Filing Date
2021-05-12
Accepted
2021-05-12 16:27:56
Documents
13
Period of Report
2021-05-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kdmn-20210512x8k.htm   iXBRL 8-K 145614
2 EX-10.1 kdmn-20210512xex10_1.htm EX-10.1 591986
  Complete submission text file 0001557142-21-000058.txt   927831

Data Files

Seq Description Document Type Size
3 EX-101.SCH kdmn-20210512.xsd EX-101.SCH 3071
4 EX-101.LAB kdmn-20210512_lab.xml EX-101.LAB 15502
5 EX-101.PRE kdmn-20210512_pre.xml EX-101.PRE 11475
6 EXTRACTED XBRL INSTANCE DOCUMENT kdmn-20210512x8k_htm.xml XML 4813
Mailing Address 450 EAST 29TH STREET NEW YORK NY 10016
Business Address 450 EAST 29TH STREET NEW YORK NY 10016 833-900-5366
Kadmon Holdings, Inc. (Filer) CIK: 0001557142 (see all company filings)

IRS No.: 273576929 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37841 | Film No.: 21915507
SIC: 2834 Pharmaceutical Preparations